Please assess the completion status of the following clinical trial:

Trial Title: ABRA Abdominal Closure System in Open Abdomen Management

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. ages of 18 and 70~2. patients deemed not a candidate for primary fascial closure at the second laparotomy.~Exclusion Criteria:~1. High risk for imminent death, as determined by the attending surgeon and PI~2. Pre-existing large ventral hernia~3. Significant loss of abdominal wall fascia as a result of trauma or infection~4. Known Crohn's disease~5. Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 ABRA plus KCI ABThera or KCI VAC (Type: ACTIVE_COMPARATOR): ABRA Abdominal Wound Closure System in combination with KCI ABThera or KCI VAC
- KCI V.A.C. Therapy or ABThera Alone (Type: ACTIVE_COMPARATOR): KCI V.A.C. Therapy ABThera Alone

Based on this trial design, predict the completion outcome and termination type (if applicable).